An earlier study within the PHS cohort examined a trinucleotide CAG repeat polymorphism in AR. Shorter AR CAG repeats, which are associated with greater transactivation of the AR, were associated with higher risk of advanced prostate cancer compared with longer AR CAG repeats (Giovannucci et al, 1997). This evidence concerns the gene AR and prostate carcinoma.